In stock
ANZATAX 6MG-ML VIAL 6 concentrate for solution for injection 5ml Vial
In stock
Only 1 left
SKU
10331014139
ANZATAX 6mg/mL is a concentrate for solution for injection containing Paclitaxel, a powerful chemotherapy drug manufactured by Fresenius Kabi. It is used to treat various cancers by inhibiting cancer cell growth. Administered intravenously by healthcare professionals, this prescription-only medicine requires careful monitoring and specific storage conditions.
About ANZATAX 6mg/mL Solution for Injection
ANZATAX 6mg/mL Concentrate for Solution for Injection is a specialized medication containing Paclitaxel, an active ingredient widely recognized in oncology.
This product is manufactured by Fresenius Kabi, a global leader in healthcare specializing in life-saving medicines and technologies.
ANZATAX is formulated for intravenous administration, playing a critical role in the treatment of various types of cancer.
Benefits of Use
- Broad-Spectrum Efficacy: Paclitaxel, the active component in ANZATAX, is effective against a range of solid tumors, including ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
- Mechanism of Action: It works by disrupting the normal functioning of microtubules, essential cellular structures involved in cell division. This action inhibits cancer cell proliferation and induces apoptosis (programmed cell death), thereby slowing tumor growth.
- Established Treatment Protocol: ANZATAX is often used as a single agent or in combination with other chemotherapy drugs, following established clinical guidelines to optimize patient outcomes.
How to Use
- ANZATAX is a potent chemotherapy agent that must be administered by a qualified healthcare professional experienced in the use of antineoplastic agents.
- The concentrate must be diluted prior to intravenous infusion. The specific dilution and administration rate will be determined by the physician based on the patient's condition, cancer type, and treatment protocol.
- It is typically administered as an intravenous infusion over several hours.
- Treatment cycles and duration vary depending on the specific cancer indication and patient response.
- Patients will be closely monitored for adverse reactions during and after administration.
Caution & Warnings
- This medication is for intravenous use only and must not be administered by any other route.
- ANZATAX can cause severe hypersensitivity reactions, so patients should be pre-medicated before administration.
- Monitor complete blood counts regularly due to the risk of bone marrow suppression (myelosuppression), particularly neutropenia.
- Peripheral neuropathy is a common dose-limiting toxicity; patients should be monitored for neurological symptoms.
- Not recommended for use in pregnant or breastfeeding women due to potential harm to the fetus or infant.
- Store the concentrate vials at controlled room temperature, typically below 25°C, and protect from light.
- Keep out of reach of children and pets.
Ingredients
- Active Ingredient: Paclitaxel 6mg/mL
- Excipients: Purified Castor Oil (Polyoxyethylated), Dehydrated Alcohol (Ethanol)
Product Details
- Brand: Fresenius Kabi
- Manufacturer: Fresenius Kabi
- Form: Concentrate for solution for injection
- Strength: 6 mg/mL
- Package Size: 5 mL Vial
- Drug Type: Prescription Only Medicine
| Gtin | 1301256586 |
|---|---|
| Recommended Sale Price | 135.15 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | PACLITAXEL |
| SFDA Reg. No | 1301256586 |
| IBC | 1301256586 |
| Drug Type | Prescription |
| Scientific Name | Paclitaxel |
| Strength | 6 mg/mL |
| Strength Unit | mg/mL |
| Form | Concentrate for solution for injection |
| Admin Route | Intravenous |
| Size | 5 mL |
| Size Unit | mL |
| Package Types | Vial |
| Package Size | 1 |
| Storage conditions | Store below 25°C, protect from light |
| Refrigerator Storage | No |
Products you might like
